Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 12,194,000 | 8,836,000 | 4,320,000 | 16,323,000 | 13,802,000 |
| Depreciation Amortization | 2,713,000 | 1,784,000 | 895,000 | 3,895,000 | 2,904,000 |
| Income taxes - deferred | 233,000 | 284,000 | 545,000 | 441,000 | 297,000 |
| Accounts receivable | -908,000 | -1,181,000 | -786,000 | -275,000 | -453,000 |
| Other Working Capital | -426,000 | -2,011,000 | -3,054,000 | -855,000 | -1,555,000 |
| Other Operating Activity | 678,000 | 632,000 | 952,000 | -819,000 | -889,000 |
| Operating Cash Flow | $14,484,000 | $8,344,000 | $2,872,000 | $18,710,000 | $14,106,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -477,000 | -115,000 | -433,000 | 917,000 | 2,263,000 |
| Net Acquisitions | -233,000 | -233,000 | -233,000 | -2,129,000 | -291,000 |
| Purchase Of Investment | -28,766,000 | -20,813,000 | -7,162,000 | -34,913,000 | -25,784,000 |
| Sale Of Investment | 23,167,000 | 15,829,000 | 6,050,000 | 24,119,000 | 14,576,000 |
| Other Investing Activity | -35,000 | -11,000 | -11,000 | -299,000 | -147,000 |
| Investing Cash Flow | $-6,344,000 | $-5,343,000 | $-1,789,000 | $-12,305,000 | $-9,383,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,107,000 | 1,024,000 | 589,000 | 1,863,000 | 629,000 |
| Debt Issued | 3,000 | 3,000 | 3,000 | 2,098,000 | 17,000 |
| Debt Repayment | -27,000 | -21,000 | -16,000 | -1,844,000 | -1,787,000 |
| Common Stock Issued | 550,000 | 506,000 | 584,000 | 1,543,000 | 1,406,000 |
| Common Stock Repurchased | -3,394,000 | -3,094,000 | -2,198,000 | -7,124,000 | -4,381,000 |
| Dividend Paid | -6,101,000 | -4,025,000 | -1,946,000 | -7,768,000 | -5,812,000 |
| Other Financing Activity | -980,000 | -395,000 | -243,000 | -1,267,000 | -1,713,000 |
| Financing Cash Flow | $-7,842,000 | $-6,002,000 | $-3,227,000 | $-12,499,000 | $-11,641,000 |
| Exchange Rate Effect | -1,182,000 | -883,000 | -391,000 | -310,000 | -191,000 |
| Beginning Cash Position | 14,523,000 | 14,523,000 | 14,523,000 | 20,927,000 | 20,927,000 |
| End Cash Position | 13,639,000 | 10,639,000 | 11,988,000 | 14,523,000 | 13,818,000 |
| Net Cash Flow | $-884,000 | $-3,884,000 | $-2,535,000 | $-6,404,000 | $-7,109,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,484,000 | 8,344,000 | 2,872,000 | 18,710,000 | 14,106,000 |
| Capital Expenditure | -2,097,000 | -1,308,000 | -543,000 | -3,714,000 | -2,218,000 |
| Free Cash Flow | 12,387,000 | 7,036,000 | 2,329,000 | 14,996,000 | 11,888,000 |